Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD. What advantages do they offer over antibodies?  

Science 130

Science Molecular Biology Therapies Disease 130

The Pharma Data

APRIL 28, 2021

Researchers are also using sophisticated machine learning and artificial intelligence to illuminate predictive relationships from highly complex and multi-modal data, including clinical, molecular, and digital data. These analytical tools are giving teams a look at diseases at a digital pathology level. Source link.

Molecular Biology 40

Molecular Biology Doctors Disease Treatment 40

Drug Target Review

FEBRUARY 26, 2024

Rather than solely identifying tumour-associated mutations which can be specifically targeted for effective treatment, we now need to consider how non-mutational events play into both the development of the primary tumour and the development of therapy resistance.

Therapies 59

Therapies Molecular Biology Regulations Medical Schools 59

Drug Target Review

SEPTEMBER 22, 2023

Moreover, their intricate 3D structure and cellular diversity offer a more precise replication of specific structures and functions, making them promising candidates in disease modelling and drug testing. CRISPR engineering in organoids for gene repair and disease modelling. Available from: [link] Geurts MH, Clevers H. 95: 729–38

Clinical Research 116

Clinical Research Research Drug Development Molecular Biology 116

Broad Institute

JANUARY 30, 2024

In others, an infection can cause the immune system to spin out of control, leading to sepsis — organ dysfunction that lacks effective treatments and is often fatal. Bhattacharyya’s work in Sosnick’s lab solidified his interests in biology and biochemistry, but he also had a growing desire to practice medicine.

Hospitals 137

Hospitals Medical Schools Virus Science 137

Drug Discovery World

NOVEMBER 9, 2023

Alessa Schaffrath, Doctoral Student, UKE Hamburg, on: ‘Transgenic llama mice – a fast and flexible single domain discovery tool’. Sandra Ergueta-Carballo, PhD, Project Coordinator, University of Cambridge, on: ‘Advancing snake envenomation treatment: designing the next generation of antivenoms’.

Engineering 130

Engineering Therapies Protein Production Science 130

Drug Target Review

AUGUST 29, 2023

I then chose to do my doctoral research at the Perelman School of Medicine at the University of Pennsylvania, which provided me with great scientific training, critical thinking, and communication skills. in cell and molecular biology with a focus in cancer biology from the Perelman School of Medicine at the University of Pennsylvania.

Science 98

Science Molecular Biology Disease Therapies 98